
Organization
The WIN Consortium is organized in the following groups who collectively work together to achieve WIN's common goals
“A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology” Published by Therapeutic Advances in Medical Oncology
WIN was formed on the premise that we can accomplish more together than each organization can achieve working alone. We aim to improve cancer patients’ survival and quality of life. View WIN's history and unique attributes:
WIN members collaboratively design and carry out global studies designed to achieve breakthroughs for patients worldwide. Our distinguished Scientific Advisory Board oversees WIN studies. Current trials include:
WIN leaders are selected for their contributions and commitment to making effective, personalized cancer medicine a reality for patients around the world. They guide WIN's strategic, operational, and scientific direction.
The WIN Consortium is organized in the following groups who collectively work together to achieve WIN's common goals
Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Chief Medical Officer, WIN Consortium; Professor of Medicine, Associate Director, Clinical Research, Linda T. and John A. Mellowes Endowed Chair of Precision Oncology (USA)
Chief Scientific and Operating Officer, WIN Consortium
Director, Operational Team, WIN Consortium
WIN members include 31 leading organizations representing all stakeholders in personalized cancer medicine covering 19 countries and 5 continents. Our shared vision is delivering the promise of effective, personalized cancer medicine to patients worldwide.
WIN Symposia, held annually, gathers leaders representing a breadth of stakeholders from around the world to learn, share, and collaborate. Visit http://www.winsymposium.org for registration and additional information.
WIN 2022 Symposium
October 29, 2022 - October 30, 2022The WIN 2022 Symposium ‘Integrating Genomics and Transcriptomics to Reshape Precision Oncology: A WINning Strategy’ took place on 29-30 October, 2022 in Barcelona, Spain.
We had an exciting line-up of prominent speakers and panel discussion and our 1st international molecular board!
For further information, please visit our dedicated symposium website https://www.winsymposium.org!
Partnership JIPO and WIN
December 03, 2021 - December 03, 2022JIPO and WIN will cross-promote both organization’s activities throughout the year, including the WIN 2022 Symposium in Barcelona, Spain, October 29-30, 2022. Abstracts selected for presentation at the WIN meeting will be published in JIPO as a Conference Proceeding.
JIPO Editorial Fellow, Dr. Khalid Jazieh, will be interviewing members of WIN Leadership to highlight the collaboration and upcoming activities. Drs. Razelle Kurzrock, Vladimir Lazar, and Richard L. Schilsky will be interviewed. These interviews will be published on the JIPO YouTube channel in the coming weeks.
Dr. Vladimir Lazar, Chief Scientific and Operating Officer of WIN, has been appointed to the JIPO Editorial Board to represent WIN Leadership. Dr. Lazar plans to contribute an editorial to the Journal in 2022. Dr. Kurzrock has published four articles in JIPO in 2019 and 2020.
WIN 2019 Symposium
June 23, 2019 - June 24, 2019The 11th edition of the WIN Symposia ‘WINnovation and Global Deployment of Precision Oncology’ took place in Paris, France on 23-24 June 2019.
Highlights and further information on the event, WIN 2019 can be found on our dedicated website at https://www.winsymposium.org/